CUSIP: 71426V108
Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
43,461,693
-
Share change
-
-1,926,071
-
Total reported value
-
$128,198,181
-
Price per share
-
$2.95
-
Number of holders
-
96
-
Value change
-
-$7,235,655
-
Number of buys
-
43
-
Number of sells
-
41
Quarterly Holders Quick Answers
What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2016
-
Previous quarter:
Q3 2015
Recent filing periods for CUSIP 71426V108:
Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q4 2015
As of 31 Dec 2015,
PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,461,693 shares.
The largest 10 holders included
Broadfin Capital, LLC, MORGAN STANLEY, venBio Select Advisor LLC, Stonepine Capital Management, LLC, Elk Creek Partners, LLC, Aisling Capital LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and ORBIMED ADVISORS LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.